The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Patrick H. Maxwell(Centre for Human Genetics), Michael S. Wiesener(Centre for Human Genetics), Gin-Wen Chang(Centre for Human Genetics), Steven C. Clifford(University of Birmingham), Emma C. Vaux(John Radcliffe Hospital), Matthew E. Cockman(John Radcliffe Hospital), Charles C. Wykoff(John Radcliffe Hospital), Christopher W. Pugh(John Radcliffe Hospital), Eamonn R. Maher(University of Birmingham), Peter J. Ratcliffe(John Radcliffe Hospital)
Nature
May 1, 1999
10.1038/20459
Cited by 5,198

Abstract

Related Papers

Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
Douglas Hanahan, Judah Folkman|Cell|1996|6.9k
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Dorit Shweiki, Ahuva Itin, Dov Soffer et al.|Nature|1992|4.6k
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Peter Carmeliet, Yuval Dor, Jean-Marc Herbert et al.|Nature|1998|2.5k
Mutations of the VHL tumour suppressor gene in renal carcinoma
James R. Gnarra, Kálmán Tory, Y Weng et al.|Nature Genetics|1994|1.7k
Hypoxia-inducible Factor 1α (HIF-1α) Protein Is Rapidly Degraded by the Ubiquitin-Proteasome System under Normoxic Conditions
Susana Alicia Salceda, J. Jaime|Journal of Biological Chemistry|1997|1.7k